Allogene Therapeutics, Inc.

ALLO·NASDAQ·$2.12Share Price as of 11/2·$517MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report09/02/26 8-KCurrent report08/12/26 8-KCurrent report06/22/26 8-KCurrent report05/28/26 8-KCurrent report05/13/26

Prospectuses and Registrations

S-3Shelf registration08/12/26 424B5Prospectus supplement06/22/26 424B5Prospectus supplement04/15/26 424B5Prospectus supplement04/13/26 S-8Registration of securities for employees03/12/26

Proxies

DEFA14AAdditional proxy materials05/28/26 DEFA14AAdditional proxy materials05/21/26 DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 PRE 14APreliminary proxy04/20/26

Ownership

Form 4Insider transaction10/23/26 144Proposed sale of securities10/21/26 SC 13D/ABeneficial ownership (amended)09/30/26 Form 4Insider transaction08/25/26 144Proposed sale of securities08/21/26

Other

EFFECTRequest for effectiveness08/20/26 ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/30/25 EFFECTRequest for effectiveness04/25/24 ARSAnnual report to shareholders04/23/24